Bedfont Scientific Granted FDA’s 510(k) Clearance for Its Airway Monitor

UK-based Bedfont Scientific’s NObreath FeNO airway inflammation monitor has received the FDA’s 510(k) clearance.

The portable device measures exhaled nitric oxide in human breath that can be used to help diagnose an inflammatory condition, because the human body often produces more nitric oxide when suffering from inflammatory conditions, such as asthma.

The monitor can help identify patients who do or do not require ongoing treatment and can differentiate between allergic and nonallergic asthma, the company said.